NCT00861419 2017-02-08To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.AmgenPhase 1 Completed88 enrolled
NCT01128998 2015-10-19Sorafenib Plus S-1 in Advanced Solid TumorsNational Health Research Institutes, TaiwanPhase 1 Completed30 enrolled